Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ)
CNY 6.11
(-0.49%)
CNY 6.11
(-0.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 137.01 Million | 40.71 Million | 887.77 Thousand | 86.13 Million | -36.02 Million | -84.14 Million |
| Net Income | 15.68 Million | -137.92 Million | -505.78 Million | -7.55 Million | 2.02 Million | 77.5 Million |
| Depreciation & Amortization | 112.91 Million | 109.36 Million | 107.65 Million | 89.92 Million | 73.26 Million | 67.55 Million |
| Deferred income taxes | -2.6 Million | -2.65 Million | -195.76 Thousand | 4.13 Million | 2.37 Million | 17.92 Million |
| Stock-based compensation | - | - | - | - | - | -1.94 Million |
| Change in working capital | -41.51 Million | 22.49 Million | -14.94 Million | -44.17 Million | -169.21 Million | -190.78 Million |
| Other non-cash items | 36.82 Million | 46.77 Million | 413.96 Million | 47.93 Million | 57.88 Million | -38.42 Million |
| Investing Cash Flow | -169.27 Million | -139.77 Million | -379 Million | -361.04 Million | -130.87 Million | -47.65 Million |
| Investments in PPE | -197.54 Million | -161.45 Million | -367.05 Million | -202.33 Million | -108.86 Million | -53.29 Million |
| Acquisitions | 21.78 Million | 400.1 Million | 278.4 Thousand | -26.03 Million | 71.7 Thousand | 233.35 Thousand |
| Investment purchases | - | -1000.00 | -14 Million | -753.68 Million | -10 Million | -33 Million |
| Sales/Maturities of investments | 4.99 Million | 1006.41 | 3.19 Million | 757.08 Million | -71.7 Thousand | 200 Thousand |
| Other Investing Activities | 1.49 Million | -378.41 Million | -1.42 Million | -136.08 Million | -12 Million | 5.43 Million |
| Financing Cash Flow | 8.24 Million | 172.6 Million | 369.64 Million | 288.77 Million | 94.06 Million | 166.9 Million |
| Debt repayment | -4.81 Million | -562.31 Million | -612.3 Million | -1.12 Billion | -298.37 Million | -280.59 Million |
| Dividends payments | -51.14 Million | -26.74 Million | -25.94 Million | -27.26 Million | -29.49 Million | -16.74 Million |
| Common Stock Repurchased | - | - | - | - | -9.9 Million | -7.76 Million |
| Common Stock Issuance | - | - | - | - | 9.9 Million | - |
| Other Financing Activities | 64.2 Million | 761.66 Million | 1 Billion | 1.43 Billion | 421.92 Million | 464.25 Million |
| Accounts receivables | 1.7 Million | 44.99 Million | 60.96 Million | -71.64 Million | 35.79 Million | -51.58 Million |
| Accounts payables | -56.56 Million | 30.99 Million | -44.31 Million | -7.14 Million | -91.82 Million | -60.95 Million |
| Inventory | 15.95 Million | -50.83 Million | -31.4 Million | 30.47 Million | -115.54 Million | -96.16 Million |
| Other working capital | -59.17 Million | -2.65 Million | -195.76 Thousand | 4.13 Million | 2.37 Million | -94.61 Million |
| Cash at beginning of period | 107.8 Million | 34.46 Million | 43.18 Million | 30.01 Million | 102.51 Million | 67.27 Million |
| Cash at end of period | 83.78 Million | 107.8 Million | 34.46 Million | 43.18 Million | 30.01 Million | 102.51 Million |
| Capital Expenditure | -197.54 Million | -161.45 Million | -367.05 Million | -202.33 Million | -108.86 Million | -53.29 Million |
| Effect of forex changes on cash | -5981.41 | -212.41 Thousand | -242.45 Thousand | -687.16 Thousand | 337.59 Thousand | 136.47 Thousand |
| Net cash flow / Change in cash | -24.01 Million | 73.33 Million | -8.72 Million | 13.17 Million | -72.5 Million | 35.23 Million |
| Free Cash Flow | -60.52 Million | -120.73 Million | -366.17 Million | -116.19 Million | -144.89 Million | -137.44 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.91 Million | 7.77 Million | 19.86 Million | 15.68 Million | -39.06 Million | 8.21 Million |
| Depreciation & Amortization | - | 29.29 Million | 29.29 Million | 112.91 Million | 112.91 Million | -55.89 Million |
| Deferred income taxes | - | - | - | -2.6 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -41.51 Million | 17.65 Million | -48.81 Million |
| Other non-cash items | -25.69 Million | 7.14 Million | 12.04 Million | 36.82 Million | -58.1 Million | 119.72 Million |
| Investing Cash Flow | -42.9 Million | -35.41 Million | -72.54 Million | -169.27 Million | -18.47 Million | -46.55 Million |
| Investments in PPE | -44.07 Million | -35.47 Million | -72.66 Million | -197.54 Million | -40.42 Million | -48.49 Million |
| Acquisitions | 4000.00 | 58.39 Thousand | 120 Thousand | 21.78 Million | 21.74 Million | 21.79 Thousand |
| Investment purchases | - | - | - | - | - | -21.79 Thousand |
| Sales/Maturities of investments | - | - | - | 4.99 Million | 240.83 Thousand | 1.3 Million |
| Other Investing Activities | 1.17 Million | 58.39 Thousand | 120 Thousand | 1.49 Million | -37.71 Thousand | 629.18 Thousand |
| Financing Cash Flow | 104.68 Million | 45.36 Million | 26.94 Million | 8.24 Million | 4.68 Million | -3.69 Million |
| Debt repayment | -27.59 Million | -25.21 Million | -140.16 Million | -4.81 Million | -11.79 Million | -289.64 Million |
| Dividends payments | -9.4 Million | -5.8 Million | -8.04 Million | -51.14 Million | -12.55 Million | -8.51 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 86.49 Million | 25.95 Million | -105.17 Million | 64.2 Million | 5.44 Million | 294.46 Million |
| Accounts receivables | - | - | - | 1.7 Million | 1.7 Million | -14.16 Million |
| Accounts payables | - | - | - | -56.56 Million | - | - |
| Inventory | - | - | - | 15.95 Million | 15.95 Million | -34.65 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 65.13 Million | 69.46 Million | 83.78 Million | 107.8 Million | 63.63 Million | 91.23 Million |
| Cash at end of period | 97.27 Million | 65.13 Million | 69.46 Million | 83.78 Million | 83.78 Million | 63.63 Million |
| Capital Expenditure | -44.07 Million | -35.47 Million | -72.66 Million | -197.54 Million | -40.42 Million | -48.49 Million |
| Effect of forex changes on cash | -37.41 Thousand | 113.41 Thousand | -627.62 Thousand | -5981.41 | 548.37 Thousand | -581.46 Thousand |
| Net cash flow / Change in cash | 32.13 Million | -4.32 Million | -14.32 Million | -24.01 Million | 20.15 Million | -27.6 Million |
| Free Cash Flow | -73.68 Million | -49.86 Million | -40.75 Million | -60.52 Million | -7.02 Million | -25.26 Million |
XFAB
5928
5922
CLBR
5440
CIBUS